Document is current
Any future updates will be listed below
-
Authors
Brierley, Daniel I. https://orcid.org/0000-0002-4360-2648
Holt, Marie K.
Singh, Arashdeep https://orcid.org/0000-0002-2477-1438
de Araujo, Alan https://orcid.org/0000-0003-2656-4077
McDougle, Molly
Vergara, Macarena https://orcid.org/0000-0003-3823-979X
Afaghani, Majd H. https://orcid.org/0000-0003-0408-5243
Lee, Shin Jae
Scott, Karen https://orcid.org/0000-0002-4133-423X
Maske, Calyn
Langhans, Wolfgang https://orcid.org/0000-0001-9742-0068
Krause, Eric https://orcid.org/0000-0002-2718-3113
de Kloet, Annette
Gribble, Fiona M. https://orcid.org/0000-0002-4232-2898
Reimann, Frank https://orcid.org/0000-0001-9399-6377
Rinaman, Linda https://orcid.org/0000-0001-5999-8811
de Lartigue, Guillaume https://orcid.org/0000-0002-0032-8810
Trapp, Stefan https://orcid.org/0000-0003-0665-4948
-
Funding
Funding for this research was provided by:
Wellcome Trust (106262/Z/14/Z, 106263/Z/14/Z)
RCUK | Medical Research Council (MRC_MC_UU_12012/3, MR/N02589X/1)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK100685, R01 DK116004)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH059911)
- License Information
-
More Information
Article History
Received: 4 August 2020
Accepted: 13 January 2021
First Online: 15 February 2021
Competing interests
: The F.R. and F.M.G. laboratory receives funding from AstraZeneca, Eli Lilly and LGM for unrelated research and F.M.G. consults for Kallyope (New York). All other authors have no competing interests to declare.
